The Valley Desk

ArticleThe oncologistPublished

Outcomes after SRS and ipilimumab plus nivolumab for melanoma brain metastases following prior immune checkpoint inhibitor or targeted therapy

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
The oncologist
Published
Subject terms
Humans; Melanoma; Brain Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Radiosurgery; Retrospective Studies; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male
PubMed ID
41693007
PubMed Central ID
PMC13010309
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal